Key takeaways
The cost of GLP-1s without insurance depends on the medication, the dose, and where you fill your prescription.
Without insurance, GLP-1s for weight loss cost $122–$1,639 per month, while GLP-1s for type 2 diabetes cost $149–$1,476 per month.
You may be able to lower the cost of GLP-1s with cash-pay prices, when available, or a prescription discount card.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
The cost of GLP-1s without insurance depends on the medication, the dose, and where you fill your prescription.
Without insurance, GLP-1s for weight loss cost $122–$1,639 per month, while GLP-1s for type 2 diabetes cost $149–$1,476 per month.
You may be able to lower the cost of GLP-1s with cash-pay prices, when available, or a prescription discount card.
The cost of GLP-1s without insurance depends on the medication, the dose, and where you fill your prescription. Cash-pay prices for GLP-1 pills and injections start at $149 per month on Ro, while list and retail prices can top $1,600 per month. If your insurance stopped covering your GLP-1 or you are uninsured, several options may help lower that cost.
Cost of GLP-1s for weight loss without insurance
Without insurance, GLP-1s forweight loss cost between $122 and $1,639 for a monthly supply. The cost can vary depending on the medication, the dose, and how you fill your prescription.
Here are the list, retail, and cash prices for a one-month supply of injections and pills approved for weight loss:
GLP-1 | Cost without insurance |
Foundayo (orforglipron) pill | $649 (list price) $764.10–$788.70 (retail price) $149–$299* (cash price on Ro) |
Wegovy (semaglutide) pill | $1,349.02 (list price) $1,587–$1,638.90 (retail price) $149–$299* (cash price on Ro) |
Wegovy (semaglutide) injection | $1,349.02 (list price) $1,196.24–$1,327.23 (retail price) $199–$399* (cash price on Ro) |
Zepbound (tirzepatide) injection | $499–$1,086.37 (list price; pen) $1,000.15–$1,058.11 (retail price; pen) $586.99–$606.70 (retail price; KwikPen) $299–$449* (cash price on Ro; KwikPen) |
Saxenda (liraglutide) injection | $1,349.02 (list price) $1,391.26–$1,429.56 (retail price) |
Generic liraglutide injection | $121.50–307.59 (retail price) |
*Terms and restrictions may apply for certain doses. Prices may reflect limited-time offers and are subject to change; see more here.
The list price is the wholesale price set by the manufacturer. Retail pharmacies set their own prices, so the retail price can be higher or lower than the list price depending on the pharmacy and location. When available, cash-pay prices from manufacturers and telehealth partners such as Ro are among the lowest-cost options for GLP-1 weight loss medications.
Cost of GLP-1s for diabetes without insurance
Without insurance, GLP-1s for diabetes cost between $149 and $1,476 for a monthly supply. The cost can vary depending on the medication, the dose, and how you fill your prescription.
Here are the prices for a one-month supply of injectable and oral medications approved for type 2 diabetes:
GLP-1 | Cost without insurance |
Ozempic (semaglutide) pill | $1,027.51 (list price) $985.16–$1,009.73 (retail price) $149–$299* (cash price with manufacturer savings offer) |
Ozempic (semaglutide) injection | $1,027.51 (list price) $1,212.99–$1,475.70 (retail price) $199–$499* (cash price with manufacturer savings offer) |
Mounjaro (tirzepatide) injection | $1,112.16 (list price) $1,312–$1,351.70 (retail price) $499 (cash price with manufacturer savings offer) |
Victoza (liraglutide) injection | $543.51–$815.27 (list price) $570.91–$578.95 (retail price) |
Generic liraglutide injection | $266.60–$644.09 (retail price) |
*Terms and restrictions may apply for certain doses. Prices may reflect limited-time offers and are subject to change; see more here.
How to save on the cost of GLP-1s without insurance
Even without insurance, you may be able to lower the cost of GLP-1s with cash-pay prices, patient assistance programs, prescription discount cards, and other options.
Cash-pay (self-pay)
Cash-pay is often one of the lowest-cost options for getting GLP-1s without insurance. It allows you to pay cash for your prescription when you fill it directly with the manufacturer or with one of its authorized partners, such as Ro. On Ro, you can get the following GLP-1s without insurance at cash-pay prices:
Foundayo (orforglipron): On Ro, Foundayo costs $149 for the 0.8 mg and 2.5 mg doses, $199 for the 5.5 mg dose, and $299 for the 9 mg, 14.5 mg, and 17.2 mg doses.* These prices are up to $500 less than the list price.
Wegovy pill (semaglutide): On Ro, the Wegovy pill costs $149 for the 1.5 mg dose, $199 for the 4 mg dose, and $299 for the 9 mg and 25 mg doses. These prices are more than $1,000 less than the list price.
Wegovy pen (semaglutide): On Ro, the Wegovy pen costs $199 for the 0.25 mg and 0.5 mg doses, $349 for the 1 mg and 2.4 mg doses, and $399 for the 7.2 mg HD dose. These prices are $950–$1,150 cheaper than the list price.
Zepbound (tirzepatide): On Ro, the Zepbound KwikPen costs $299 for the 2.5 mg dose, $399 for the 5 mg dose, and $449 for the 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses.* These prices are $200–$640 cheaper than the list price for Zepbound.
*Terms and restrictions may apply for certain doses. Prices may reflect limited-time offers and are subject to change; see more here. Medication costs are in addition to the Ro Body membership, which is $39 for the first month and as little as $74 per month with a prepaid annual plan.
Patient assistance programs
Manufacturers may offer patient assistance programs, or PAPs, to help people with lower incomes access the medications they need. These programs typically provide the medication at no cost to people who qualify. Qualifications vary by program, but typically require household income below certain limits and either no insurance or, for some medications, Medicare.
Among its GLP-1s, Novo Nordisk includes only the Ozempic (semaglutide) pen in its PAP, and only for people without insurance. Eli Lilly only includes an older GLP-1 called Trulicity (dulaglutide) in its PAP.
Prescription discount cards
Prescription discount cards, such as those from SingleCare and GoodRx, are typically free to use and may lower the retail price of a medication at participating pharmacies. Discounts vary by pharmacy, and discount cards typically cannot be combined with other offers. Manufacturer savings cards, which can lower the cost of some GLP-1s to as little as $25 per month, are for eligible people with commercial insurance.
Compounded medications
Compounded GLP-1s often contain semaglutide or tirzepatide, but they are not FDA-approved, meaning the FDA does not review them for safety, effectiveness, or quality before they are marketed. Compounding may be appropriate in certain instances, such as when a patient’s medical need cannot be met by an FDA-approved medication.
Compounded GLP-1s may cost less than FDA-approved GLP-1s, but they are not the same. If your healthcare provider recommends compounded semaglutide or another compounded GLP-1, fill the prescription at a state-licensed compounding pharmacy that complies with federal and state laws.
Alternative coverage options
If you have insurance but it does not cover your GLP-1 for weight loss, a healthcare provider can help determine whether a GLP-1 approved for another condition is appropriate for you. Many insurance plans cover GLP-1s prescribed for type 2 diabetes, such as Ozempic, Mounjaro (tirzepatide), or Victoza (liraglutide). In a national study of US adults with type 2 diabetes, insurance paid more than 95% of GLP-1 costs in 2021–2022.
Some weight loss injections are FDA-approved for additional conditions that may be covered by insurance. For example, Zepbound is FDA-approved for moderate to severe obstructive sleep apnea (OSA) in adults with obesity, and the Wegovy pen is FDA-approved for metabolic dysfunction-associated steatohepatitis (MASH), a type of fatty liver disease, in adults with moderate to advanced liver fibrosis. Insurance may cover these medications when prescribed for those uses.
Bottom line
The cost of weight loss injections and diabetes medications can be high without insurance, but several options may help lower it:
List and retail prices for GLP-1s can be high without insurance. For weight loss, the Foundayo and Wegovy pills are among the lowest-cost options when paying cash.
For type 2 diabetes, the Ozempic pill is among the lowest-cost options when paying cash. Generic liraglutide injection has an average retail price below that of brand-name Ozempic and Mounjaro.
Self-pay discounts are often one of the lowest-cost options, but it is not offered for every GLP-1. On Ro, you can get Foundayo, Wegovy, and the Zepbound KwikPen at cash-pay prices.
Other options may help lower the cost. Prescription discount cards and patient assistance programs (PAPs) may help, while compounded medications may cost less but are not FDA-approved.
Frequently asked questions (FAQs)
How much do GLP-1s cost?
Without insurance, GLP-1s cost anywhere from $122 to more than $1,600 per month, depending on the medication and how you fill your prescription. With commercial insurance, GLP-1s may cost as low as $25 per month with manufacturer savings cards, but government plans such as Medicaid are excluded. Eligible Medicare members can access GLP-1 medications for weight loss for $50 per month through the temporary Bridge program.
What is the cheapest GLP-1 without insurance?
Among cash-pay options, the lowest-cost GLP-1s without insurance are the Foundayo and Wegovy pills, which start at $149 per month on Ro. For type 2 diabetes, the Ozempic pill costs $149–$299 per month when paying cash directly to the manufacturer. Generic liraglutide injection is also a lower-cost option, with an average retail price of $121.50–$307.59 per month.
What is the cost of GLP-1 pills without insurance?
The cost of GLP-1 pills without insurance is $149–$299 per month when paying cash, depending on the dose. This is the cash-pay price for the Foundayo and Wegovy pills, which may be prescribed for weight loss, and the Ozempic pill, which is prescribed for type 2 diabetes.
What is the cheapest way to get a GLP-1 without insurance?
Paying cash is often one of the lowest-cost options for getting a GLP-1 without insurance. Thanks to Ro’s partnerships with Eli Lilly and Novo Nordisk, you can get GLP-1 options such as Foundayo, the Zepbound KwikPen, and the Wegovy pill and pen for some of the lowest cash-pay prices. Foundayo and the Wegovy pill start at $149, the Wegovy pen starts at $199, and the Zepbound KwikPen starts at $299. Prices may reflect limited-time offers and are subject to change; see more here.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
Foundayo Important Safety Information: Read more about serious warnings and safety info.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
Ozempic Important Safety Information: Read more about serious warnings and safety info.
Mounjaro Important Safety Information: Read more about serious warnings and safety info.
References
Eli Lilly and Company-a. (2026). Available medications | Lilly Cares. Retrieved from https://www.lillycares.com/available-medications
Eli Lilly and Company-b. (2026). How much should I expect to pay for Foundayo (orforglipron)? Retrieved from https://pricinginfo.lilly.com/foundayo
Eli Lilly and Company-c. (2026). How much should I expect to pay for Mounjaro (tirzepatide)? Retrieved from https://pricinginfo.lilly.com/mounjaro
Eli Lilly and Company-d. (2026). How much should I expect to pay for Zepbound (tirzepatide)? Retrieved from https://pricinginfo.lilly.com/zepbound
Medicare.gov. (n.d.). Weight loss drugs. Retrieved from https://www.medicare.gov/coverage/weight-loss-drugs
Novo Nordisk-a. (2026). Novo Nordisk Patient Assistance Program (PAP) available products. Retrieved from https://www.novocare.com/content/dam/novonordisk/novocare/forms/PAP_Product_List.pdf
Novo Nordisk-b. (2026). Ozempic (semaglutide) cost and insurance coverage. Retrieved from https://www.ozempic.com/savings-and-resources/save-on-ozempic.html
Novo Nordisk-c. (2026). Patient assistance program. Retrieved from https://www.novocare.com/diabetes/help-with-costs/pap.html
Novo Nordisk-d. (2026). Price your Wegovy. Retrieved from https://www.novocare.com/patient/medicines/wegovy.html
Novo Nordisk. (2025). Victoza pricing. Retrieved from https://www.novopricing.com/victoza.html
Novo Nordisk-e. (2026). What is the list price for Saxenda and will it impact me? Retrieved from https://www.novocare.com/obesity/products/saxenda/explaining-list-price.html
SingleCare-a. (n.d.). Foundayo coupons & prices. Retrieved from https://www.singlecare.com/prescription/foundayo
SingleCare-b. (n.d.). Liraglutide coupons & prices. Retrieved from https://www.singlecare.com/prescription/liraglutide
SingleCare-c. (n.d.). Mounjaro coupons & prices. Retrieved from https://www.singlecare.com/prescription/mounjaro?q=Mounjaro
SingleCare-d. (n.d.). Ozempic coupons & prices. Retrieved from https://www.singlecare.com/prescription/ozempic?q=Ozempic
SingleCare-e. (n.d.). Saxenda coupons & prices. Retrieved from https://www.singlecare.com/prescription/saxenda?q=Saxenda
SingleCare-f. (n.d.). Victoza coupons & prices. Retrieved from https://www.singlecare.com/prescription/victoza?q=Victoza
SingleCare-g. (n.d.). Wegovy coupons & prices. Retrieved from https://www.singlecare.com/prescription/wegovy?q=Wegovy
SingleCare-h. (n.d.). Zepbound coupons & prices. Retrieved from https://www.singlecare.com/prescription/zepbound?q=Zepbound
U.S. Food and Drug Administration (FDA-a). (2026). FDA’s concerns with unapproved GLP-1 drugs used for weight loss. Retrieved from https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
U.S. Food and Drug Administration (FDA-b). (2026). Highlights of prescribing information: Wegovy (semaglutide) injection, for subcutaneous use; Wegovy (semaglutide) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/218316s007lbl.pdf
U.S. Food and Drug Administration (FDA-c). (2026). Highlights of prescribing information: Zepbound (tirzepatide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806Orig1s041correctedlbl.pdf
Wu, J., Perez, A., & Sullivan, P. W. (2025). Patterns and costs associated with glucagon-like peptide-1 receptor agonist use in US adults with type 2 diabetes. Journal of Managed Care & Specialty Pharmacy, 31(10), 1029–1038. doi: 10.18553/jmcp.2025.31.10.1029. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12467763/














